ADXN vs GILD: Which Stock is Better?
Side-by-side comparison of Addex Therapeutics Ltd and Gilead Sciences Inc in 2026
ADXN
Addex Therapeutics Ltd
$7.17
GILD
Gilead Sciences Inc
$143.93
Key Metrics Comparison
| Metric | ADXN | GILD | Winner |
|---|---|---|---|
| Market Cap | $8.83M | $178.68B | GILD |
| P/E Ratio | N/A | 21.42 | GILD |
| EPS (TTM) | $N/A | $6.72 | GILD |
| Revenue Growth | -0.1% | 0.0% | GILD |
| Gross Margin | -331.6% | 78.8% | GILD |
Analyze ADXN
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADXN or GILD a better investment?
Comparing ADXN and GILD: Addex Therapeutics Ltd has a market cap of $8.83M while Gilead Sciences Inc has $178.68B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADXN and GILD?
ADXN (Addex Therapeutics Ltd) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADXN or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ADXN or GILD?
GILD has higher revenue growth at 0.0% vs -0.1% for ADXN.
Which company is more profitable: ADXN or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -331.6% for ADXN.
Which is the larger company: ADXN or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $178.68B compared to $8.83M for ADXN.
Should I buy ADXN or GILD in 2026?
Both ADXN and GILD have investment merit. ADXN trades at $7.17 while GILD trades at $143.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADXN and GILD stock?
Key differences: Market Cap ($8.83M vs $178.68B), P/E Ratio (N/A vs 21.4x), Revenue Growth (-0.1% vs 0.0%), Gross Margin (-331.6% vs 78.8%).